ICOS Capital invests in Mevaldi B.V., a producer of cost-effective, bio-based chemical building blocks, to support its further industrial scale up and commercial roll-out

Dutch biotech company Mevaldi B.V. announces an investment by ICOS Capital, alongside High-Tech Gründerfonds and ICIG Ventures.

Mevaldi is a biotech company and pioneer in the field of building blocks for sustainable polymers and polyurethanes made from natural biological raw materials. Since 2020, the company has been developing 3MPD: an innovative product derived from sugars and wood residues, produced through a patented bio-thermochemical process. Mevaldi makes materials with high performance, low environmental impact, and a competitive price – with the entire production chain located within Europe. In this way, Mevaldi contributes competitively to the EU’s strategic autonomy, circular economy, and climate objectives.

The financing by ICOS Capital provides Mevaldi with additional resources to accelerate its industrial scale-up and commercial roll-out activities, aimed at providing the market with affordable chemical building blocks for a wide range of sustainable chemicals and applications. Mevaldi fits ICOS Capital’s strategy as it is ready to scale-up in a capital-efficient manner, and accelerates sustainability with breakthrough solutions that are cost-efficient, have clear market traction and proven scalability. ICOS Capital joins Mevaldi with High-Tech Gründerfonds (HTGF) and ICIG Ventures (ICIG), both from Germany.

HTGF is one of the leading and most active early-stage investors in Germany and Europe. Fund investors include the Federal Ministry for Economic Affairs and Energy, KfW Capital, and 45 companies and family offices. HTGF provides capital, expertise and strong networks to support founders in turning innovative ideas into international market leaders. The fund strengthens the technological backbone of Germany and Europe.

ICIG Ventures is the venture capital arm of International Chemical Investors Group (ICIG), investing in early-stage ventures in industrial biotechnology, chemistry, materials, energy, and food/agriculture to drive strategic innovation for the larger group’s chemical platforms, focusing on bio-based solutions, advanced materials, and process efficiency.

Peter van Gelderen, General Partner of ICOS, quotes: “We are very pleased to invest in Mevaldi given it’s attractive, CAPEX light scale-up trajectory and relatively straightforward road to multiple markets. With the current consortium of strong industrial partners with existing chemical production facilities where Mevaldi’s green chemical building blocks can be produced at an attractive cost price, already at relatively low scale.”

Roger Ottenheym, CEO Mevaldi, adds: “Next to HTGF and ICIG Ventures, we are proud to bring another strong investor with industrial mindset, and backing from the chemical and bio-based industries, to our shareholder base. We are working to rapidly scale and bring to market several bio-based building blocks that can be applied in existing, as well as new applications. We believe that our sustainable competitive edge and contribution to CO2 emissions reduction, at cost parity with fossil alternatives, will allow us to build a strong market position. We look forward to working with ICOS, providing us with financing, strategic insight, hands-on support and access to their industry network.”

About Mevaldi
Mevaldi is a biotech company and a pioneer in the field of bio-based building blocks for sustainable polymers, polyesters, and polyurethanes. Since 2020, the company has been developing 3MPD: an innovative building block derived from sugars and wood residues, produced through a patented bio-thermochemical process. This results in high-performance materials with low environmental impact and competitive pricing – with the entire production chain located within Europe. In this way, Mevaldi contributes competitively to the EU’s strategic autonomy, circular economy, and climate goals.

For more information, please visit mevaldi.com or follow us on LinkedIn.

About ICOS
Capital ICOS Capital is a climate tech venture capital firm that invests in early-stage companies with breakthrough technologies for food systems, chemicals, materials, and industrial digitization, aiming to accelerate sustainability and decarbonization. Over almost 20 years, ICOS has built a strong collaborative model, partnering with large corporations to provide hands-on support, access to networks, as well as capital for innovative startups focused on large-scale impact and circularity, targeting significant CO₂ reductions. ICOS supports growth with financing, engineering and production expertise, infrastructure and market access. Learn more by visiting www.icoscapital.com.

About ICIG – International Chemical Investors Group
International Chemical Investors Group (ICIG) is a privately owned industrial group with a total turnover of more than €4.6 billion. ICIG focuses on several main platforms: Fine Chemicals under the WeylChem brand, Care Chemicals (Catexel), Chlorovinyls (Vynova), Compounds (Benvic), Hydrocarbons & Solvents (HCS Group), Superabsorbents (Stockhausen Superabsorber) and Enterprises with specialized businesses in industrial drying services, fermentation products, viscose filaments, activated carbon and wood protection chemicals.

Today, the ICIG companies employ more than 7,150 people and operate more than 50 production sites in Europe, the U.S and India.

For more information, please visit ic-investors.com or follow us on LinkedIn.

About HTGF – High-Tech Gründerfonds
HTGF is one of the leading and most active early-stage investors in Germany and Europe, financing startups in the fields of Deep Tech, Industrial Tech, Climate Tech, Digital Tech, Life Sciences and Chemistry. With its experienced investment team, HTGF supports startups in all phases of their development into international market leaders. HTGF invests in pre-seed and seed phases and can participate significantly in later-stage financing rounds.

Since its inception in 2005, HTGF has financed more than 800 startups and achieved almost 200 successful exits. HTGF has a fund volume of over 2 billion euros. Fund investors in the public-private partnership include the Federal Ministry for Economic Affairs and Energy, KfW Capital as well as 45 companies and family offices.

For more information, please visit HTGF.de or follow us on LinkedIn.